Cargando…

KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc

BACKGROUND: Cancer cells maintain energy metabolism mainly by glycolysis, even under sufficient oxygen conditions. It gives cancer cells better growth advantages under complicated internal environment. KPNA2 is a novel oncogene that has received much attention in recent years, but the exact mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jie, Liu, Qian, Liu, Zihao, Xia, Qian, Zhang, Zihao, Zhang, Rui, Gao, Taihong, Gu, Guangyan, Wang, Yanan, Wang, Dan, Chen, Xiuyang, Yang, Yihang, He, Dong, Xin, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097452/
https://www.ncbi.nlm.nih.gov/pubmed/30115078
http://dx.doi.org/10.1186/s13046-018-0861-9
_version_ 1783348307527991296
author Li, Jie
Liu, Qian
Liu, Zihao
Xia, Qian
Zhang, Zihao
Zhang, Rui
Gao, Taihong
Gu, Guangyan
Wang, Yanan
Wang, Dan
Chen, Xiuyang
Yang, Yihang
He, Dong
Xin, Tao
author_facet Li, Jie
Liu, Qian
Liu, Zihao
Xia, Qian
Zhang, Zihao
Zhang, Rui
Gao, Taihong
Gu, Guangyan
Wang, Yanan
Wang, Dan
Chen, Xiuyang
Yang, Yihang
He, Dong
Xin, Tao
author_sort Li, Jie
collection PubMed
description BACKGROUND: Cancer cells maintain energy metabolism mainly by glycolysis, even under sufficient oxygen conditions. It gives cancer cells better growth advantages under complicated internal environment. KPNA2 is a novel oncogene that has received much attention in recent years, but the exact mechanisms of KPNA2 in tumorigenesis and progression are largely unknown. Especially its potential roles in the metabolic transformation of tumors still remain to be explored. METHODS: The expressions of KPNA2 in glioblastoma and normal human brain samples were analyzed by immunohistochemical analysis. The activities of key enzymes in glycolysis, the production of lactate acid and glucose uptake were investigated by colorimetry. GLUT-1 expression was measured by flow cytometry. CCK8 was used to examine the cell viability in vitro, and the xenograft models in nude mice were established to explore the roles of KPNA2 in vivo. In addition, Co-IP, subcellular fractionation, western blot, immunofluorescence and luciferase assay were used to investigate the internal connection between KPNA2, c-myc and E2F1. RESULTS: In the present study, we found that KPNA2 was highly expressed in the glioma compared to the normal brain tissues. Level of KPNA2 was an independent predictor of prognosis in the glioma patients. Knockdown of KPNA2 in the glioblastoma cell lines U87 and U251 decreased deoxyglucose uptake, activities of the key glycolytic enzymes and lactate production. The level of oxidative phosphorylation (OXPHOS) was moderately decreased. Additioanlly, tumor proliferation and invasiveness were concomitantly downregulated. We have identified c-myc as a potential mediator of KPNA2. Aberrant expression of KPNA2 significantly changed the subcellular distribution of c-myc as well as its expression level. E2F1, another key cargo protein of KPNA2, was further identified to play a potential role in regulating the transcription of c-myc by KPNA2. CONCLUSIONS: Our findings suggested that KPNA2, a potential tumor oncogene, performs its function in part via regulating cellular metabolism through c-myc signaling axis. It would provide a possible explanation for Warburg effect and thus offer a new perspective to the roles of KPNA2 in gliomagenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0861-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6097452
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60974522018-08-20 KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc Li, Jie Liu, Qian Liu, Zihao Xia, Qian Zhang, Zihao Zhang, Rui Gao, Taihong Gu, Guangyan Wang, Yanan Wang, Dan Chen, Xiuyang Yang, Yihang He, Dong Xin, Tao J Exp Clin Cancer Res Research BACKGROUND: Cancer cells maintain energy metabolism mainly by glycolysis, even under sufficient oxygen conditions. It gives cancer cells better growth advantages under complicated internal environment. KPNA2 is a novel oncogene that has received much attention in recent years, but the exact mechanisms of KPNA2 in tumorigenesis and progression are largely unknown. Especially its potential roles in the metabolic transformation of tumors still remain to be explored. METHODS: The expressions of KPNA2 in glioblastoma and normal human brain samples were analyzed by immunohistochemical analysis. The activities of key enzymes in glycolysis, the production of lactate acid and glucose uptake were investigated by colorimetry. GLUT-1 expression was measured by flow cytometry. CCK8 was used to examine the cell viability in vitro, and the xenograft models in nude mice were established to explore the roles of KPNA2 in vivo. In addition, Co-IP, subcellular fractionation, western blot, immunofluorescence and luciferase assay were used to investigate the internal connection between KPNA2, c-myc and E2F1. RESULTS: In the present study, we found that KPNA2 was highly expressed in the glioma compared to the normal brain tissues. Level of KPNA2 was an independent predictor of prognosis in the glioma patients. Knockdown of KPNA2 in the glioblastoma cell lines U87 and U251 decreased deoxyglucose uptake, activities of the key glycolytic enzymes and lactate production. The level of oxidative phosphorylation (OXPHOS) was moderately decreased. Additioanlly, tumor proliferation and invasiveness were concomitantly downregulated. We have identified c-myc as a potential mediator of KPNA2. Aberrant expression of KPNA2 significantly changed the subcellular distribution of c-myc as well as its expression level. E2F1, another key cargo protein of KPNA2, was further identified to play a potential role in regulating the transcription of c-myc by KPNA2. CONCLUSIONS: Our findings suggested that KPNA2, a potential tumor oncogene, performs its function in part via regulating cellular metabolism through c-myc signaling axis. It would provide a possible explanation for Warburg effect and thus offer a new perspective to the roles of KPNA2 in gliomagenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0861-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-16 /pmc/articles/PMC6097452/ /pubmed/30115078 http://dx.doi.org/10.1186/s13046-018-0861-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Li, Jie
Liu, Qian
Liu, Zihao
Xia, Qian
Zhang, Zihao
Zhang, Rui
Gao, Taihong
Gu, Guangyan
Wang, Yanan
Wang, Dan
Chen, Xiuyang
Yang, Yihang
He, Dong
Xin, Tao
KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc
title KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc
title_full KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc
title_fullStr KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc
title_full_unstemmed KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc
title_short KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc
title_sort kpna2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097452/
https://www.ncbi.nlm.nih.gov/pubmed/30115078
http://dx.doi.org/10.1186/s13046-018-0861-9
work_keys_str_mv AT lijie kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc
AT liuqian kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc
AT liuzihao kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc
AT xiaqian kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc
AT zhangzihao kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc
AT zhangrui kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc
AT gaotaihong kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc
AT guguangyan kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc
AT wangyanan kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc
AT wangdan kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc
AT chenxiuyang kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc
AT yangyihang kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc
AT hedong kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc
AT xintao kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc